![]() |
Birmingham, Water's Edge |
|
|
![]() |
University
of Birmingham |
Queen
Elizabeth Hospital |
| HEAD OF THE UNIT | Prof C. Savage, Dr G. Lipkin |
| CLINICAL STAFF | Dr D ADU
Consultant Physician & Nephrologist |
| RESEARCH STAFF |
Dr R BATES Research
Fellow |
| CONTACT
INFORMATION |
|
| Bindu.Gohil@uhb.nhs.uk | |
| PHONE: | +44-121-4721311 |
| FAX: | +44-121-6272527 |
| FULL POSTAL ADDRESS | University Hospital Birmingham Nhs Trust, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK |
| WEBSITE OF THE UNIT | www.uhb.nhs.uk |
| CLINICAL
FACILITIES |
|
| NEPHROLOGY BEDS N° | 54 |
| HEMODIALYSIS PATIENTS N° | 736 (March 2003) |
| PERITONEAL DIALYSIS PATIENTS N° | 163 (March 2003) |
| INTENSIVE CARE NEPHROLOGY BEDS N° | 6 (acute renal failure) |
| RENAL TRANSPLANTS /YEAR (2002) N° | 130 (April 2002) |
RESEARCH INTERESTS
RESEARCH
PROGRAMMES AND PROJECTS LIST
RESEARCH LIST
1. ASTRAL – angioplasty and stent versus medical management
for renal arterial lesions
2. RAP09 – rapamune plus cyclosporine in failing renal transplants
3. CAESAR – mycophenolate mofetil and zenepax in renal transplant patients
4. Assessment of outcome of pregnancy in patients with renal disease
5. Cardiac Transplant assessment of potential renal transplant recipients
6. Arterial stiffness in chronic kidney disease
7. The role of aldosterone in cardiovascular disease in chronic renal failure
8. Central aortic pressure augmentation as a predictor of mortality and cardiovascular
events in chronic renal failure and renal transplant recipients
9. The GLOBAL fluid study – multi-centre PD study
10. Anti-tnf therapy in systemic vasculitis
11. MBL polymorphisms in systemic vasculitis
12. Rehabilitation, exercise and/or psychological support in systemic vasculitis
13. IMPROVE
14. CRIB Cardiovascular Risk in Birmingham
15. SHARP – multi-centre trial of lipid lowering in CRF
16. The influence of genetic loci on renal damage and disease progression
in ANCA associated vasculitis
17. Studies of the role of renal histological damage on progression in patients
with glomerulonephritis
18. Therapeutic strategies in lupus nephritis with a focus on the development
of novel therapies
Peer Reviewed Publications in International Journals (only English) 2000-2003
Publications list
2003
| Williams JM, Ben-Smith A, Hewins P*, Dove SK, Hughes P, McEwan R, Wakelam MJ*, Savage CO*. Activation of the G(i) Heterotrimeric G Protein by ANCA IgG F(ab')(2) Fragments Is Necessary but not Sufficient to Stimulate the Recruitment of Those Downstream Mediators Used by Intact ANCA IgG. Journal of the American Society of Nephrology 2003; 14(3): 661-9 |
| Sharif K, Beath SV, Kelly DA*, McKiernan P, Van Mourik I, Mirza D*, Mayer AD*, Buckels JA*, De Ville De Goyet J. New perspective for the management of near-total or total intestinal aganglionosis in infants. J Pediatr Surg 2003; 38(1): 25-8 |
| Hewins P*, Savage C*. Anti-neutrophil cytoplasm antibody associated vasculitis. International Journal of Biochemistry and Cell Biology 2003; 35(3): 277-82 |
2002
| Cooper JC, Hughes S, Ben-smith A, Savage COS*, Winer JB*. T cell recognition of a non-protein antigen preparation of Campylobacter jejuni in patients with Guillain-Barre syndrome. Journal of Neurology, Neurosurgery and Psychiatry 2002; 72: 413-414 |
| Kamesh L*, Harper L*, Savage CO*. ANCA-Positive Vasculitis.. Journal of the American Society of Nephrology 2002; 13(7): 1953-60 |
| Howie AJ*, Buist LJ*, Coulthard MG. Reflux nephropathy in transplants. Pediatric Nephrology 2002; 17(7): 485-90 |
| Beath S, de Ville de Goyet J, Kelly D*, McKiernan P, Buckels J*, Mirza D*, Mayer A*. Induction therapy for small bowel transplant recipients: early experience in Birmingham, UK. Transplantation Proceedings 2002; 34(5): 1892 |
| Mayer A*. Chronic rejection and graft half-life: five-year follow-up of the European Tacrolimus Multicentre renal study. Transplantation Proceedings 2002; 34(5): 1491 |
| Ray S, Samuel T*, Hawker J, Smith S*. Hepatitis B immunisation in renal units in the United Kingdom: questionnaire study. BMJ 2002; 324(7342): 877-8 |
| Winer J*, Hughes S, Cooper J*, Ben-Smith A, Savage C*. gamma delta T cells infiltrating sensory nerve biopsies from patients with inflammatory neuropathy. Journal of Neurology 2002; 249(5): 616-21 |
| Cockwell P*, Calderwood JW, Brooks CJ, Chakravorty SJ, Savage CO*. Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines. Nephrology, Dialysis, Transplantation 2002; 17(5): 734-44 |
| Zehnder D*, Bland R, Chana RS*, Wheeler DC*, Howie AJ*, Williams MC, Stewart PM*, Hewison M. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. Journal of the American Society of Nephrology 2002; 13(3): 621-9 |
| Cockwell P*, Chakravorty SJ, Girdlestone J, Savage CO*. Fractalkine expression in human renal inflammation. Journal of Pathology 2002; 196(1): 85-90 |
| Samuel T*, Cockwell P*. Islet cell transplantation. Journal of the Royal Society of Medicine 2002; 95(1): 31-3 |
| Benson SR, Ready AR*, Savage CO*. Donor platelet and leukocyte load identify renal allografts at an increased risk of acute rejection. TRANSPLANTATION 2002; 73(1): 93-100 |
| Harper L*, Nuttall SL, Martin U*, Savage CO*. Adjuvant treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis with vitamins E and C reduces superoxide production by neutrophils. Rheumatology (Oxford) 2002; 41(3): 274-278 |
| Savage CO*. The evolving pathogenesis of systemic vasculitis. Clin Med 2002; 2(5): 458-64 |
| Tauro S, Clark FJ*, Duncan N*, Lipkin G*, Richards N*, Mahendra P*. Recovery of renal function after autologous stem cell transplantation in myeloma patients with end-stage renal failure. Bone Marrow Transplantation 2002; 30(7): 471-3 |
| Eardley KS*, Wan DI, Thomas ME, Banerjee AK, Radojkovic M, Taylor JL. Transplant-associated inflammatory breast disease. Nephrology, Dialysis, Transplantation 2002; 17(3): 512-5 |
| Inston NG*, Cockwell P*. The evolving role of chemokines and their receptors in acute allograft rejection. Nephrology, Dialysis, Transplantation 2002; 17(8): 1374-9 |
| Chakravorty SJ, Cockwell P*, Girdlestone J, Brooks CJ, Savage CO*. Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion. Clinical and Experimental Immunology 2002; 129(1): 150-9 |
| Holland M, Takada K, Okumoto T, Takahashi N, Kato K, Adu D*, Ben-Smith A, Harper L*, Savage CO*, Jefferis R. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clinical and Experimental Immunology 2002; 129(1): 183-90 |
| Brooks S, Morgan M*. Accuracy of clinical diagnosis in knee arthroscopy. Annals of the Royal College of Surgeons of England 2002; 84(4): 265-8 |
| Savage CO*, Harper L*, Holland M. New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis. Current Opinion in Rheumatology 2002; 14(1): 15-22 |
| Eardley KS*, Jones HE, Osman H*, Smith SA*. Efficacy of the accelerated hepatitis B vaccination schedule used in haemodialysis patients post-exposure to virus: a single-centre experience. Nephrology, Dialysis, Transplantation 2002; 17(11): 1982-7 |
2001
| Balding CE, Howie AJ*, Drake-Lee AB*, Savage CO*. Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis.. Clinical and Experimental Immunology 2001; 125(2): 332-339 |
| Landray MJ*, Thambyrajah J, McGlynn FJ*, Jones HJ, Baigent C, Kendall MJ*, Townend JN*, Wheeler DC*. Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. American Journal of Kidney Diseases 2001; 38(3): 537-546 |
| De groot K, Adu D*, Savage COS*. The value of pulse cyclophosphamide in ANCA-associated vasculitis. Metanalysis and critical review. Nephrology, Dialysis, Transplantation 2001; 16: 2018-2027 |
| Day C, Savage COS*, Jones EL*, Cockwell P*. Henoch-Schonlein nephritis and non-Hodgkin's lymphoma. Nephrology, Dialysis, Transplantation 2001; 16: 1080-1081 |
| Adu D*, Cross J, Jayne DR. Treatment of systemic lupus erythematosus with mycophenolate mofetil. LUPUS 2001; 10(3): 203-208 |
| Harper L*, Radford D, Plant T, Drayson M*, Adu D*, Savage CO*. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients. Arthritis and Rheumatism 2001; 44(4): 921-930 |
| Howie AJ*, Ferreira MA, Adu D*. Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrology, Dialysis, Transplantation 2001; 16(6): 1163-1169 |
| Harper L*, Cockwell P*, Adu D*, Savage CO*. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney International 2001; 59(5): 1729-1738 |
| Thambyrajah J, Landray MJ*, Jones HJ, McGlynn FJ*, Wheeler DC*, Townend JN*. A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. Journal of the American College of Cardiology 2001; 37(7): 1858-1863 |
| Radford DJ, Luu NT, Hewins P*, Nash GB*, Savage CO*. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis and Rheumatism 2001; 44(12): 2851-61 |
| Chakravorty SJ, Howie AJ*, Girdlestone J, Gentle D, Savage CO*. Potential role for monocyte chemotactic protein-4 (MCP-4) in monocyte/macrophage recruitment in acute renal inflammation. Journal of Pathology 2001; 194(2): 239-246 |
| Adu D*. The evidence base for the treatment of lupus nephritis in the new millennium. Nephrology, Dialysis, Transplantation 2001; 16(8): 1536-1538 |
| Tse WY, Williams J, Pall A, Wilkes M*, Savage CO*, Adu D*. Antineutrophil cytoplasm antibody-induced neutrophil nitric oxide production is nitric oxide synthase independent. Kidney International 2001; 59(2): 593-600 |
| Dmitrewski J*, Krentz AJ, Mayer AD*, Buckels JA*, Barnes AD*, Smith J, Nattrass M*. Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation. Diabetes Obes Metab 2001; 3(4): 287-292 |
| Harper L*, Savage CO*. Leukocyte-endothelial interactions in antineutrophil cytoplasmic antibody-associated systemic vasculitis. Rheumatic Diseases Clinics of North America 2001; 27(4): 887-903 |
| Eardley KS*, Raza K, Adu D*, Situnayake RD. Gold treatment, nephrotic syndrome, and multi-organ failure in a patient with adult onset Still's disease. Annals of the Rheumatic Diseases 2001; 60(1): 37015- |
| Savage CO*. ANCA-associated renal vasculitis. Kidney International 2001; 60(4): 1614-27 |
| Pal BR, Preston PR, Morgan ME*, Rushton DI, Durbin GM. Frontal horn thin walled cysts in pre-term neonates are benign. Archives of Disease in Childhood. Fetal and Neonatal Edition 2001; 85(3): F187-93 |
| Ben-Smith A, Dove SK, Martin A, Wakelam MJ*, Savage CO*. Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcgamma receptor ligation. BLOOD 2001; 98(5): 1448-1455 |
European
Fellows programme
Specify
if the Unit accepts fellows from European countries for:
Short (1-2 month) well focused training programs either clinically or
laboratory oriented: Not usually.
Long (at least 1 year) research fellowships: Yes subject to funding
availabilty.
Specify corresponding availability of grants: No.
Specify if the Unit may provide help for accommodation: Yes.
Prerequisites for Fellowship
Language: English
Work/Research experience: Experience equivalent to MRCP part 2 for clinical studies/laboratory experience desirable for research studies.